We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$174M
AUM Growth
-$2.27M
Cap. Flow
+$10.4M
Cap. Flow %
6.01%
Top 10 Hldgs %
63.46%
Holding
237
New
6
Increased
44
Reduced
166
Closed
21

Top Buys

Rank Stock Value
1
CBUS icon
Cibus
CBUS
+$22.7M
2
BW icon
Babcock & Wilcox
BW
+$14.2M
3
CMA
Comerica
CMA
+$237K
4
PANW icon
Palo Alto Networks
PANW
+$207K
5
ZION icon
Zions Bancorporation
ZION
+$206K

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.73%
2 Healthcare 25.28%
3 Industrials 9.63%
4 Technology 6.93%
5 Consumer Staples 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
126
Elevance Health
ELV
$90.6B
$248K 0.14%
559
-40
-7% -$18.5K
AIG icon
127
American International
AIG
$39.7B
$247K 0.14%
4,297
-495
-10% -$26.6K
HIG icon
128
Hartford Financial Services
HIG
$36.8B
$247K 0.14%
3,432
-196
-5% -$13.8K
KMI icon
129
Kinder Morgan
KMI
$68.5B
$247K 0.14%
14,350
-845
-6% -$14.3K
PEG icon
130
Public Service Enterprise Group
PEG
$35.1B
$247K 0.14%
3,941
-581
-13% -$36.3K
AEP icon
131
American Electric Power
AEP
$65.7B
$246K 0.14%
2,924
+18
+0.6% +$1.59K
FE icon
132
FirstEnergy
FE
$26.2B
$246K 0.14%
6,332
-352
-5% -$13.8K
CNP icon
133
CenterPoint Energy
CNP
$25B
$246K 0.14%
8,435
-804
-9% -$23.8K
VTRS icon
134
Viatris
VTRS
$19.1B
$245K 0.14%
24,599
+617
+3% +$5.89K
MNST icon
135
Monster Beverage
MNST
$87.4B
$245K 0.14%
8,542
-1,630
-16% -$46.4K
NEE icon
136
NextEra Energy
NEE
$169B
$245K 0.14%
3,305
-183
-5% -$13.9K
KDP icon
137
Keurig Dr Pepper
KDP
$42.9B
$244K 0.14%
7,811
+394
+5% +$12.9K
ZTS icon
138
Zoetis
ZTS
$30.3B
$244K 0.14%
1,415
-71
-5% -$12.3K
KO icon
139
Coca-Cola
KO
$382B
$243K 0.14%
4,041
-261
-6% -$16.2K
VRTX icon
140
Vertex Pharmaceuticals
VRTX
$130B
$243K 0.14%
690
-145
-17% -$48.9K
MS icon
141
Morgan Stanley
MS
$324B
$243K 0.14%
2,842
+16
+0.6% +$1.37K
TAP icon
142
Molson Coors Class B
TAP
$7.32B
$242K 0.14%
3,681
-1,183
-24% -$73.1K
OGN icon
143
Organon & Co
OGN
$3.59B
$242K 0.14%
11,616
+1,053
+10% +$22.9K
FTNT icon
144
Fortinet
FTNT
$126B
$242K 0.14%
3,196
-2,578
-45% -$175K
LLY icon
145
Eli Lilly
LLY
$1.01T
$242K 0.14%
515
-247
-32% -$104K
DTE icon
146
DTE Energy
DTE
$27.1B
$241K 0.14%
2,192
-246
-10% -$27.4K
NXPI icon
147
NXP Semiconductors
NXPI
$57.1B
$240K 0.14%
1,171
-125
-10% -$22.2K
MRK icon
148
Merck
MRK
$355B
$239K 0.14%
2,075
-147
-7% -$16.7K
D icon
149
Dominion Energy
D
$56.2B
$239K 0.14%
4,606
-180
-4% -$9.79K
JNJ icon
150
Johnson & Johnson
JNJ
$644B
$239K 0.14%
1,441
-137
-9% -$22.1K

Similar funds

Vantage Consulting Group's Q2 2023 Portfolio in Review

As of Q2 2023, Vantage Consulting Group held 237 positions worth $174M, down 1.3% from $176M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Vantage Consulting Group deployed $10.4M of net new capital in Q2 2023, opening 6 new positions and adding to 44 existing holdings. Its largest new stake was Cibus: 1,262,842 shares worth $13.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Royalty Pharma, an estimated $12.6M trimmed.

  • Vantage Consulting Group's largest Q2 2023 buy was Cibus: 1,262,842 shares worth $13.3M.
  • Vantage Consulting Group added most to Comerica in Q2 2023, an estimated $237K increase.
  • Vantage Consulting Group's biggest Q2 2023 reduction was Royalty Pharma, cutting an estimated $12.6M.
  • Vantage Consulting Group fully exited General Mills in Q2 2023, selling an estimated $237K.
  • Vantage Consulting Group's ten largest holdings make up 63% of its $174M portfolio in Q2 2023.
  • Vantage Consulting Group opened 6 new positions and closed 21 in Q2 2023.
  • Vantage Consulting Group's portfolio value fell 1.3% quarter-over-quarter to $174M.

Based on Vantage Consulting Group's 13F filing for Q2 2023, filed 11 Aug 2023.